[Metabolic syndrome in dialyzed patients. Diagnosis and insulin resistance].
The criteria for diagnosis of metabolic syndrome (MeS) in patients treated with intermittent hemodialysis or peritoneal dialysis are presented in the paper. Metabolic syndrome is diagnosed in more than 60% of dialyzed patients, but components of MeS, especially hypertension, are much more frequently, also in patients in whom there is no basis for the diagnosis. Increased insulin resistance is a symptom, that in dialysis patients is associated with loss of muscle mass. This is one of the causes of protein malnutrition, despite the concomitant determined abdominal obesity.